Extended interval dosing of natalizumab in multiple sclerosis

L Zhovtis Ryerson; T C Frohman; J Foley; I Kister; B Weinstock-Guttman; C Tornatore; K Pandey; S Donnelly; S Pawate; R Bomprezzi; D Smith; C Kolb; S Qureshi; D Okuda; J Kalina; Z Rimler; R Green; N Monson; T Hoyt; M Bradshaw; J Fallon; E Chamot; M Bucello; S Beh; G Cutter; E Major; J Herbert; E M Frohman

doi:10.1136/jnnp-2015-312940

Article info

Multiple sclerosis

Research paper

Extended interval dosing of natalizumab in multiple sclerosis

Authors

L Zhovtis Ryerson Department of Neurology, Langone Medical Center, New York University, New York, New York, USA PubMed articles Google scholar articles
T C Frohman Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articles Google scholar articles
J Foley Rocky Mountain MS Clinic, Salt Lake City, Utah, USA PubMed articles Google scholar articles
I Kister Department of Neurology, Langone Medical Center, New York University, New York, New York, USA PubMed articles Google scholar articles
B Weinstock-Guttman University of Buffalo, Buffalo, New York, USA PubMed articles Google scholar articles
C Tornatore Georgetown University, Washington DC, USA PubMed articles Google scholar articles
K Pandey Barnabas Health MS Center, Livingston, New Jersey, USA PubMed articles Google scholar articles
S Donnelly CUNY Graduate Center, New York, New York, USA PubMed articles Google scholar articles
S Pawate Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articles Google scholar articles
R Bomprezzi University of Massachusetts School of Medicine, Worcester, Massachusetts, USA PubMed articles Google scholar articles
D Smith Multiple Sclerosis Center of Connecticut, Norwich, Connecticut, USA PubMed articles Google scholar articles
C Kolb University of Buffalo, Buffalo, New York, USA PubMed articles Google scholar articles
S Qureshi Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articles Google scholar articles
D Okuda Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articles Google scholar articles
J Kalina Department of Neurology, Langone Medical Center, New York University, New York, New York, USA PubMed articles Google scholar articles
Z Rimler Department of Neurology, Langone Medical Center, New York University, New York, New York, USA PubMed articles Google scholar articles
R Green Barnabas Health MS Center, Livingston, New Jersey, USA PubMed articles Google scholar articles
N Monson Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articles Google scholar articles
T Hoyt Rocky Mountain MS Clinic, Salt Lake City, Utah, USA PubMed articles Google scholar articles
M Bradshaw Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articles Google scholar articles
J Fallon Department of Neurology, Langone Medical Center, New York University, New York, New York, USA PubMed articles Google scholar articles
E Chamot University of Alabama School of Public Health, Birmingham, Alabama, USA PubMed articles Google scholar articles
M Bucello University of Buffalo, Buffalo, New York, USA PubMed articles Google scholar articles
S Beh Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articles Google scholar articles
G Cutter University of Alabama School of Public Health, Birmingham, Alabama, USA PubMed articles Google scholar articles
E Major National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA PubMed articles Google scholar articles
J Herbert Department of Neurology, Langone Medical Center, New York University, New York, New York, USA PubMed articles Google scholar articles
E M Frohman Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Bioengineering, University of Texas at Dallas, Dallas, Texas, USA Department of Behavioural and Brain Sciences, University of Texas at Dallas, Dallas, Texas, USA PubMed articles Google scholar articles

Correspondence to Professor EM Frohman, Department of Neurology and Neurotherapeutics, University of Texas Southwestern School of Medicine, 5323 Harry Hines Blvd, Dallas, TX 75390, USA; Elliot.frohman{at}utsouthwesternen.edu

View Full Text

Citation

Zhovtis Ryerson L, Frohman TC, Foley J, et al

Extended interval dosing of natalizumab in multiple sclerosis

Journal of Neurology, Neurosurgery & Psychiatry 2016;87:885-889.

Publication history

Received December 16, 2015
Revised January 25, 2016
Accepted February 6, 2016
First published February 25, 2016.

Online issue publication

July 14, 2016

Article Versions

Previous version (14 July 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password